At Johnson & Johnson, we believe a good idea can come from anywhere. Our aim is to identify, empower and enable the best ideas to get to patients and consumers around the globe. In an effort to unearth the unseen and brightest innovations in healthcare, Johnson & Johnson Innovation is launching a Quick Pitch event where innovators can apply to present to Johnson & Johnson External Innovation and R&D leadership during the week of the 37th Annual JP Morgan Healthcare Conference in San Francisco, CA.  If you are selected, you will have an opportunity to present for 5 minutes followed by a 5 minute Q&A session with Johnson & Johnson External Innovation and R&D leadership. 

If you have a novel idea that has yet to be introduced to Johnson & Johnson and fits our areas of interest, we would like to hear from you. Apply for an open spot at the Johnson & Johnson Innovation Quick Pitch event to be held on Wednesday, January 9th from 9-11am. Limited spots available. 

Applications must be submitted by December 7th.   

Areas of Interest

We encourage applications from companies working on all aspects of human healthcare, and have a particular interest in the following areas:

Pharmaceuticals
  • CAR-T and other immune cell therapy
  • Gene therapy
  • RNAi targeting and delivery approaches
  • Gene editing
  • Armed antibodies and other multi-specific biologics
  • Data Science platforms and tools
  • Retinal Diseases

Medical Devices
  • Digital Surgery (including Orthopedics, General Surgery and CSS)
    • Wearable and implantable sensors
    • Artificial Intelligence
    • AV/VR/MR
    • Advanced Imaging and Visualization
    • Robotics and Automation
    • Perioperative care/Care coordination
  • Infection
    • Prevention and Treatment in Surgery and Orthopedics
  • Tissue Regeneration
    • Scaffolds and new implantable materials
    • Biologics and growth factors
    • Early intervention in Osteoarthritis, Degenerative Disc Disease and Osteoporosis
  • General Surgery Solutions
    • Biological and synthetic technologies for stopping bleeding, sealing leaks
    • Technologies in tissue proximation and wound closure
    • Energy based technologies for surgery (cutting and coagulation) and tumor ablation
  • Interventional Solutions
    • Technologies for Neurovascular and Stroke Treatment

Consumer
  • Digital selfcare solutions
    • Pain management
    • Menopause
    • Digestive health
    • Allergy
  • Healthy Skin

Vision Care
  • Restoring Accommodation
    • Optical/opto-mechanical designs
    • Shape changing materials
    • SMART technology
  • Progressive Myopia
    • Diagnostics to predict fast vs. slow progression
    • Genetic predictors
    • Technologies to slow axial growth
  • Cataract Surgery
    • Eliminate post-operative residual refractive error 
    • Prevention of posterior capsular opacification
    • Alternative energy approaches for cataract extraction
    • Office-based cataract surgery
  • Soft Contact Lenses with Added  Functionality
    • AR, biosensors
    • Rx treatment delivery.
    • Novel materials/coatings that improve end-of-day comfort
  • Dry Eye Disease: 
    • Pharmaceuticals in late stage development
    • Biomarkers for diagnosis and drug targets
    • Drug delivery
  • Technologies for Macular Degeneration 
    • Low vision optical designs
    • Optical designs that improve off-axis image quality
    • AR/VR, visual aids, SMART technology
  • Digital Cataract Surgery
    • Artificial Intelligence
    • AV/VR/MR
    • Advanced Imaging and Visualization
    • Robotics and Automation

Cross Sector Lung Cancer
  • Digital Therapeutics for Lung Cancer prevention or interception
  • Anti-inflammatory solutions for Lung Cancer prevention or interception

Application process
Applicants will be required to submit a design. Solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:

  • Potential impact
  • Uniqueness of solution & level of competition in current market
  • Quality & feasibility of technology
  • Team credibility & capabilities

Award

  • 5 minute pitch presentation to Johnson & Johnson External Innovation and R&D leadership
  • 5 minute Q&A with Johnson & Johnson External Innovation and R&D leadership

Timeline

  • Applications open: November 14
  • Close application: December 7
  • Review Period: December 10 – 14
  • Review Call: Dec 18
  • Scheduling: Dec 19 – 21

Why this opportunity matters to us

At Johnson & Johnson Innovation, we believe a good idea can come from anywhere, and it’s our goal to find new and innovative technologies that provide solutions to patients from across the world. Working together, we can spark the next great idea that will change the trajectory of health.